| 000 | 01866 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250515150549.0 | ||
| 264 | 0 | _c20090217 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1476-5594 | ||
| 024 | 7 |
_a10.1038/onc.2008.424 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJimeno, A | |
| 245 | 0 | 0 |
_aEvaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay. _h[electronic resource] |
| 260 |
_bOncogene _cJan 2009 |
||
| 300 |
_a610-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
| 650 | 0 | 4 | _aBiopsy, Fine-Needle |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCyclin B _xmetabolism |
| 650 | 0 | 4 | _aCyclin B1 |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aSulfones _xpharmacology |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 |
_acdc25 Phosphatases _xmetabolism |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aChan, A | |
| 700 | 1 | _aCusatis, G | |
| 700 | 1 | _aZhang, X | |
| 700 | 1 | _aWheelhouse, J | |
| 700 | 1 | _aSolomon, A | |
| 700 | 1 | _aChan, F | |
| 700 | 1 | _aZhao, M | |
| 700 | 1 | _aCosenza, S C | |
| 700 | 1 | _aRamana Reddy, M V | |
| 700 | 1 | _aRudek, M A | |
| 700 | 1 | _aKulesza, P | |
| 700 | 1 | _aDonehower, R C | |
| 700 | 1 | _aReddy, E P | |
| 700 | 1 | _aHidalgo, M | |
| 773 | 0 |
_tOncogene _gvol. 28 _gno. 4 _gp. 610-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2008.424 _zAvailable from publisher's website |
| 999 |
_c18486065 _d18486065 |
||